Keywords: lti, doxil, early, phase, results, liposome, technology

LTI'S DOXIL: EARLY PHASE I RESULTS

Article | 15 June 1992

Print This

Liposome Technology has reported preliminary results from a Phase I clinical trial to determine the maximum tolerated dose of Doxil, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in